Abstract
Introduction
Glucometry is widely used to confirm or exclude hypoglycemia in patients with suggestive clinical findings. Nonglucose sugars may be detected by certain types of glucometers, causing false elevation of the glucometer analysis of the blood sugar. Since these other sugars are not functionally glucose and may even induce excess insulin release, clinical hypoglycemia may be missed.
Case Report
We report a 79-year-old man on enteral feeds containing maltodextrin, a glucose polymer, who had persistently high glucometer-measured blood glucose despite normal blood glucose measured by formal laboratory analysis.
Discussion
Excess insulin administration, based on the erroneous glucometer reading, may have caused unrecognized fatal clinical hypoglycemia. This has been reported following intravenous administration of related nonglucose sugars but not with enteral maltodextrin. Further study is required to confirm the effects of maltodextrin on glucometry.
Conclusion
False elevation of blood glucose measured on certain point-of-care glucometers can occur following the oral administration of maltodextrin.
Keywords: maltodextrin, hypoglycemia, point-of-care glucometers
Full Text
The Full Text of this article is available as a PDF (182.6 KB).
Footnotes
There was no outside funding of any kind used for this study.
References
- 1.US Food and Drug Administration, [web page on the Internet]. Important safety information on interference with blood glucose measurement following use of parenteral maltose/parenteral galactose/oral-xylose-containing products [cited 2007 November 19]. Available at: http://www.fda.gov/ cber/safety/maltose 110405.htm
- 2.Ghys T, Goedhuys W, Spincemaille K, Gorus F, Gerlo E. Plasma-equivalent glucose at the point-of-care: evaluation of Roche Accu-Chek Inform and Abbott Precision PCx glucose meters. Clin Chim Acta. 2007;386:63–68. doi: 10.1016/j.cca.2007.07.025. [DOI] [PubMed] [Google Scholar]
- 3.Newman JD, Ramsden CA, Balazs NDH. Monitoring neonatal hypoglycemia with the Accu-chek Advantage II glucose meter: The cautionary tale of galactosemia. Clin Chem. 2002;48:2071–2071. [PubMed] [Google Scholar]
- 4.Apperloo JJ, Vader HL. A quantitative appraisal of interference by icodextrin metabolites in point-of-care glucose analyses. Clin Chem Lab Med. 2005;43:314–318. doi: 10.1515/CCLM.2005.054. [DOI] [PubMed] [Google Scholar]
- 5.Mehmet S, Quan G, Thomas S, et al. Important causes of hypoglycemia in patients with diabetes on peritoneal dialysis. Diabet Med. 2001;18:679–682. doi: 10.1046/j.0742-3071.2001.00556.x. [DOI] [PubMed] [Google Scholar]
- 6.Riley SG, Chess J, Donovan KL, et al. Spurious hyperglycaemia and icodextrin in peritoneal dialysis fluid. BMJ. 2003;327:608–609. doi: 10.1136/bmj.327.7415.608. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Janssen W, Harff G, Caers M, et al. Positive interferences of icodextrin metabolites in some enzymatic glucose methods. Clin Chem. 1998;44:2379–2380. [PubMed] [Google Scholar]
- 8.Wang R, Skoufos L, Martis L. Glucose monitoring for diabetic patients using icodextrin. Perit Dial Int. 2004;24:296–297. [PubMed] [Google Scholar]
- 9.ISMP Medication Safety Alert Be aware of false glucose results with point-of-care testing. 2005;10:1–3. [Google Scholar]
- 10.Sutherland LR, Verhoef M, Wallace JL, et al. A simple, non-invasive marker of gastric damage: sucrose permeability. Lancet. 1994;343:998–1000. doi: 10.1016/S0140-6736(94)90125-2. [DOI] [PubMed] [Google Scholar]
- 11.Sjöstedt Zsigmond C, Hannestad U, Franzén L, et al. Atrophic gastritis is associated with increased sucrose permeability related to chronic inflammation. Digestion. 2005;72:201–206. doi: 10.1159/000089145. [DOI] [PubMed] [Google Scholar]
- 12.Asano T, Greenberg BZ, Wittmers PV, et al. Xylitol, a partial homologue of alpha-D-glucopyranose: a potent stimulator of insulin release in dogs. Endocrinology. 1977;100:339–345. doi: 10.1210/endo-100-2-339. [DOI] [PubMed] [Google Scholar]